Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02787213 · ClinicalTrials.gov registry record
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A clinical trial of Preterm Birth, sponsored by Sera Prognostics.
- Completed
- Registry status
- 5,011
- Enrollment target
- 18
- Study locations
NCT02787213: Completed study of Preterm Birth, sponsored by Sera Prognostics.
NCT02787213 is a study of Preterm Birth that has completed, run by Sera Prognostics. The registered enrollment target is 5,011 participants, above the 4,281-participant average among 39 other Preterm Birth trials with a reported enrollment target (17% higher). The trial reports 18 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02787213, a study of Preterm Birth, has completed, sponsored by Sera Prognostics.
- COMPLETED
- Registry status
- 5,011 participants
- Enrollment target
- 18
- Study locations
Study Summary
Prospective multicenter observational study to further develop and validate a preterm birth risk predictor, using a preterm cutoff at 37 0/7 weeks gestation and at 35 0/7 weeks gestation. A single maternal peripheral blood sample will be collected for analysis. Data related to potential risk factors for preterm birth will be obtained through maternal interview and review of medical records. Subjects will be followed through the delivery process to assess the course of pregnancy, labor, and to document any related maternal complications. Neonatal outcomes will be gathered from the medical record for up to 28 days of life or discharge, whichever occurs first.
Conditions Studied
Study Locations (18)
California
- University of California, Irvine Medical Center - Orange
- UC San Diego Health - San Diego
Colorado
- University of Colorado-Denver - Aurora
- Denver Health Medical Center - Denver
Massachusetts
- Boston Medical Center - Boston
- Baystate Medical Center - Springfield
North Carolina
- University of North Carolina - Chapel Hill
- Duke University Medical Center - Durham
South Carolina
- Medical University of South Carolina - Charleston
- Greenville Health System - Greenville
Arizona
- Maricopa Integrated Health Systems - Phoenix
Illinois
- Northwestern Memorial Hospital - Chicago
Indiana
- Indiana University Medical Center - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,011 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-06 |
What the finished NCT02787213 record still lists
NCT02787213 is an observational study that tracks outcomes without assigning an intervention. Its 5,011 participants enrollment target places it among the larger protocols in the corpus, above the 4,281-participant average among 39 other Preterm Birth trials with a reported enrollment target (17% higher).
The record links to 1 condition, with Preterm Birth appearing as the primary indexed condition, and to 0 interventions.
NCT02787213 lists 18 locations in 13 states (California, Colorado, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT02787213 about?
NCT02787213 is a clinical study titled "A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor". Prospective multicenter observational study to further develop and validate a preterm birth risk predictor, using a preterm cutoff at 37 0/7 weeks gestation and at 35 0/7 weeks gestation. A single maternal peripheral blood sample will be collected for analysis. Data related to potential risk factors...
What is the current status of trial NCT02787213?
This trial is currently completed. The enrollment target is 5,011 participants. The study started on 2016-08. Estimated completion is 2019-06.
What conditions does trial NCT02787213 study?
This clinical trial studies the following conditions: Preterm Birth.
Who is sponsoring clinical trial NCT02787213?
This trial is sponsored by Sera Prognostics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02787213 being conducted?
This trial has 18 study locations across Arizona, California, Colorado, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02787213's enrollment target sits among peer trials
5,011 7th of 39 higher than 33 of 39 other Preterm Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preterm Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transition From Donor Milk: a Feasibility Study
RECRUITING · NA
-
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
RECRUITING · Phase 4
-
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
RECRUITING · NA
-
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
RECRUITING · Phase 1
-
Stress Phenotypes and Preterm Birth
RECRUITING · NA
-
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04743362 · 5,010 participants
A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia